Umbrella Organization of European Waldenström patient supportgroups and patients

European
WALDENSTRÖM'S
MACROGLOBULINEMIA
network

Clinical Trials

Understanding Clinical Trials
The US National Institutes of Health/National Cancer Institute has developed a set of questions for cancerpatients to discuss with their physician: More information
 

Questions to Ask Your Doctor about Treatment Clinical Trials
If you are thinking about taking part in a clinical trial, be sure to ask your doctor, “Is there a clinical trial that I can join?”
If your doctor offers you a trial, here are some questions you may want to ask.
More information


European Consortium for Waldenstrom Macroglobulinemia (ECWM)
The ECWM joins forces in Europe in a consortium, which has the vision to combine the expertise of clinicians, pathologists and researchers across Europe to develop novel strategies to diagnose, prognostify and treat patients with WM.
The ECWM is based on a clinical intergroup connecting all major clinical national study groups. This clinical intergroup forms a unique platform for setting up large clinical and innovative trials in a rare disease such as WM.
Currently several clinical trials are initiated which offer patients with WM novel therapeutic approaches in the setting of well controlled clinical trials.

At www.ecwm.eu you can find more information.

Waldenström's Macroglobulinemia Clinical Trials Group (WMCTG)

The WMCTG is comprised of over 20 major cancer centers around the world. Their mission is to maintain active clinical trials year round in an effort to constantly improve the understanding and continue to offer patients the most effective treatments for Waldenström's macroglobulinemia. By maintaining an extensive contingent of collaborating centers, they hope to be better able to enroll patients in the trials without delay. Not only does the WMCTG allow more convenient patient access to treatment, but will also facilitate completion of clinicl tials in a more timely manner.

At www.wmctg.org you can find more information about the physicians belonging to the WMCTG, including six European members and see in what WM clinical trials each one of them is involved.

8th International Workshop on Waldenstrom's Macroglobulinemia
London, August 14-16, 2014

Professor C. Buske, Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital Ulm Germany
Setting up clinical trials in WM
Abstract. under construction   for the full presentation click here: Setting up clinical trials in WM


More information on WM and clinical trials is available at the following websites:

This is a website under permanent construction made by WM patients for WM patients.We will add new information in due time.
Disclaimer : By your use of the EWMnetwork for information and communication you relieve EWMnetwork of any responsibility
for the content of this website. Links to third-party sites appearing on this website are supplied for information only and EWMnetwork
cannot be held liable for the content or management of any such sites.